Doximity Stock News

Jeff Tangney, Doximity co-founder and CEO, joins 'TechCheck' to discuss the company's quarterly earnings results, potential opportunities for growth and more.

Doximity Inc (NYSE: DOCS ) posted Q3 FY22 sales of $97.9 million , an increase of 67% Y/Y, beating the consensus of $86.27 million. The adjusted EPS of $0.29 came ahead of the consensus of $0.13 and $0.07 a year ago. Non-GAAP net income rose to $63.6 million, versus $19.5 million last year, representing a 65% margin. Adjusted EBITDA of $47.0 million increased 119% Y/Y, representing adjusted EBITDA margins of 48%. Doximity generated an operating Full story available on Benzinga.com

Doximity, Inc. (NYSE:DOCS) Q3 2022 Earnings Conference Call February 08, 2022, 05:00 PM ET Company Participants Perry Gold - Head, IR Jeff Tangney - Co-Founder and CEO Anna Bryson - CFO

Doximity press release (DOCS): FQ3 Non-GAAP EPS of $0.29 beats by $0.17.Revenue of $97.88M (+66.7% Y/Y) beats by $11.61M.Shares +6.4%.Q4 Outlook: Revenue between $89.0 million and…

Doximity, Inc. (DOCS) CEO Jeff Tangney on Q3 2022 Results - Earnings Call Transcript

The stock price of Doximity, Inc. (NYSE: DOCS) increased by 8.35% after hours. This is why it happened.

Digital World Acquisition, ZIM Integrated Shipping Services, Adagio Therapeutics, Roblox, and Doximity saw the largest percentage increase in stock price since initial listing.

At the height of the pandemic, telehealth stocks became all the rage as investors concluded that virtual visits would take off since in-person consultations with a physician would be too risky.

Its future is promising, but there are still a few obstacles to overcome.

These two industry leaders have fallen far off their all-time highs, and now might be the perfect time to invest.

Doximity Inc - Class A (DOCS) shares closed today at 0.2% above its 52 week low of $40.49, giving the company a market cap of $2B. The stock is currently down 15.3% year-to-date, down 19.9% over the past 12 months, and down 19.9% over the past five years. This week, the Dow Jones Industrial Average fell 2.5%, and the S&P 500 fell 4.1%. Trading Activity Trading volume this week was 12.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 415.3% The company's stock price performance over the past 12 months lags the peer average by 44.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Doximity has a dominant hold on this lucrative niche.

Doximity has a dominant hold on this lucrative niche.

The "LinkedIn for Doctors" went public in June 2021.

SAN FRANCISCO, Jan. 18, 2022/ /PRNewswire/ -- Doximity, Inc. (NYSE:DOCS) will announce financial results for its third quarter which ended December 31, 2021 after market close on February 8, 2022. Do